Filter
220
Text search:
FDA
Featured
Recommendations
21
New Publications
30
Language
Document type
No document type
103
Guidelines
63
Studies & Reports
27
Manuals
7
Fact sheets
7
Strategic & Response Plan
6
Training Material
4
Resource Platforms
2
Situation Updates
1
Countries / Regions
India
8
Russia
8
Latin America and the Carribbean
7
Ghana
6
Philippines
4
Syria
4
South Africa
4
Ecuador
4
Uganda
3
Sudan
3
Yemen
3
Middle East and North Africa
3
South–East Asia Region
3
Western and Central Europe
3
Eastern Europe
3
Congo, Democratic Republic of
2
USA
2
Ethiopia
2
South Sudan
2
Brazil
2
Colombia
2
Myanmar / Burma
2
Asia
2
Global
2
Nigeria
1
Zimbabwe
1
Iraq
1
Jordan
1
Germany
1
Kenya
1
Tanzania
1
Thailand
1
Argentina
1
Bolivia
1
Chile
1
Paraguay
1
Africa
1
Venezuela
1
Kazakhstan
1
France
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
57
Clinical Guidelines
26
Pharmacy & Technologies
12
Women & Child Health
5
Public Health
4
Key Resources
3
Toolboxes
COVID-19
47
Mental Health
30
TB
25
HIV
22
Pharmacy
13
AMR
12
Specific Hazards
7
Ebola & Marburg
4
Rapid Response
4
Planetary Health
4
NTDs
4
Refugee
3
NCDs
3
Malaria
2
2.0 Rapid Response
2
Cholera
1
Conflict
1
Natural Hazards
1
Zika
1
Global Health Education
1
Caregiver
1
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in rare instances, by ingestion of contaminated food or
...
Bulletin of the World Health Organization; http://dx.doi.org/10.2471/BLT.16.176677
Soumis à l’Agence des États-Unis pour le développement international par le programme SIAPS (Systems for Improved Access to Pharmaceuticals and Services ou Programme des systèmes pour l’amélioration de l’accès aux produits et services pharmaceutiques). Arlington, VA : Management Sciences
...
Available in Arabic, Chinese, English, French, Portuguese and Spanish
https://apps.who.int/iris/handle/10665/334254
Consideraciones para aplicar y ajustar medidas de salud pública y sociales en el contexto de la COVID-19
recommended
orientaciones provisionales, 14 de junio de 2021
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc
...
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Orientations provisoires, 28 janvier 2021
Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les points suivants ont été ajoutés : aspects de
...
The document "Priority medical devices list for the COVID-19 response and associated technical specifications" complements this guideline.
This document provides interim guidance on the quality, performance characteristics and related standards of personal protective equipment (PPE) to be used i
...
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate
...
Временное руководство23 декабря 2020 г.
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t
...
